학술논문

Phase 2 Study of Erlotinib Combined With Adjuvant Chemoradiation and Chemotherapy in Patients With Resectable Pancreatic Cancer
Document Type
Article
Source
In International Journal of Radiation Oncology, Biology, Physics 15 July 2013 86(4):678-685
Subject
Pancreatic Cancer
Language
ISSN
0360-3016